Acute poisoning with amphetamines (MDEA) and heroin: Antagonistic effects between the two drugs

Intensive Care Medicine

Volumn 22, Issue 5, 1996, Pages 456-459

  Jorens, P G ^a   Heytens, L ^a   Demey, H E ^a   Andries, S ^b   Ricaurte, G A ^c   Bossaert, L ^a   Schepens, P J C ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Amphetamines (and analogues); Eve; Heroin; Intoxication; Methylene dioxyeth(yl) amphetamine (MDEA); Methylene dioxymethamphetamine (MDMA); Morphine; Poisoning

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; DIAMORPHINE; DIAZEPAM; FENTANYL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG BLOOD LEVEL; DRUG INTOXICATION; HUMAN; MALE;

3,4-METHYLENEDIOXYAMPHETAMINE; ACUTE DISEASE; ADULT; CONFUSION; DESIGNER DRUGS; DRUG ANTAGONISM; DRUG MONITORING; HEROIN; HUMANS; INTENSIVE CARE; MALE; NARCOTICS; SUICIDE, ATTEMPTED; TIME FACTORS;

EID: 0029943888     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01712166     Document Type: Article

References (19)

1. Dowling GP, McDonough ET III, Bost RO (1987) "Eve" and "Ecstasy." A report of five deaths associated with the use of MDEA and MDMA. JAMA 257: 1615-1617
2. Rattray M (1991) Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA. Essays Biochem 26: 77-87
3. Henry JA, Jeffreys KJ, Dawling S (1992) Toxicity and deaths from 3,4-methylene dioxymethamphetamine ("Ecstasy"). Lancet 340: 384-387
4. Tehan B, Hardern R, Bodenham A (1993) Hyperthermia associated with 3,4-methylene dioxyethamphetamine ("Eve"). Anaesthesia 48: 507-510
5. Chadwick IS, Linsley A, Freemont AJ, Doran B (1991) Ecstasy, 3,4-methylene dioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia. J R Soc Med 84: 371
6. Ricaurte G, Bryan G, Strauss L, Seiden L, Schuster C (1985) Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 229: 986-988
7. 3H] dopamin release from superfused rat brain slices. Eur J Pharmacol 132: 269-276
8. Rudnick G, Wall SC (1992) The molecular mechanism of "ecstasy" [3,4-methylene dioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci USA 89: 1817-1821
9. 2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylene dioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa. J Pharmacol Exp Ther 256: 230-235
10. Ricaurte GA, Finnegan KF, Nichols DE, DeLamey LE, Irwin I, Langston JW (1987) 3,4-Methylene dioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain. Eur J Pharmacol 137: 265-268
11. Schmidt CJ (1987) Acute administration of methylene dioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogues. Eur J Pharmacol 136: 81-88
12. Boja JW, Schechter M (1987) Behavioral effects of N-ethyl-3,4-methylenedioxyamphetaminc (MDE; "Eve"). Pharmacol Biochem Behav 28: 153-156
13. Price LP, Ricaurte GA, Krystal JH, Heninger GR (1989) Neuroendocrine and mood response to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Arch Gen Psychiatry 46: 20-28
14. Gouzoulis E, van Bardeleber U, Rupp A, Kovar KA, Hermle L (1993) Neuroendocrine and cardiovascular effects of MDE in healthy volunteers. Neuropsychopharmacology 8: 187-193
15. Moffat AC (ed) (1986) Clarke's isolation and identification of drugs. Pharmaceutical Press, London
16. Ellenhorn MJ, Barceloux DG (eds) (1988) Medical Toxicology. Diagnosis and treatment of human poisoning. Elsevier, New York
17. Hertting G, Wurster S, Allgaier C (1990) Regulatory proteins in presynaptic function. Ann NY Acad Sci 604: 289-304
18. Sawynok J (1989) The role of ascending and descending noradrenergic and serotonergic pathways in opioid and non-opioid antinociception as revealed by lesion studies. Can J Physiol Pharmacol 167: 975-988
19. Richelson E, Pfenning M (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104: 277-282